Drugs in context

Keyphrases

Publications

volume 13, 2024

Irsan Hasan, Ignatia Sinta Murti, Putut Bayupurnama, Kemal Fariz Kalista, Christina Hill-Zabala, Dennis Kananda, Elisabet Viayna
Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings. Drugs in context 13 (2024)
Laura Cristina López Vargas, David Chávez Gallegos, Dolly Marlene Blanco Borjas, Veronika J Wirtz
Medicines policy, access and use in Mexico: a systematic literature review 2000-2022. Drugs in context 13 (2024)
Coral González Fernández, Jose Antonio Ros Lucas, Maria Molina Molina, Juan Rigual Bobillo, Rogelio Alejandro García Montenegro, Raquel Fernández González, Ana Jaureguiza Oriol, Jose Abal Arca
Autoimmune findings in patients with silicosis in Spain. Drugs in context 13 (2024)
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mosges, Zoltan Novak, Papadopoulos G Nikolaos, Pablo Rodríguez Del Río, null null
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study. Drugs in context 13 (2024)
Kayla R Stover, Taylor E Jordan, Jamie L Wagner, Katie E Barber
High-dose amphotericin: yay or nay? A case series and literature review. Drugs in context 13 (2024)
Dhyuti Gupta, Prithpal Singh Matreja, Shilpa Patrick, Meenu Thomas, Pooja Agarwal, Preeti Singh
Assessment of knowledge, attitude and practice of fixed-dose combinations amongst attending physicians and residents: a cross-sectional evaluation. Drugs in context 13 (2024)
Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study. Drugs in context 13 (2024)
Emanuele Grassedonio, Lorena Incorvaia, Marco Guarneri, Fabio Guagnini, Massimo Midiri
Prevention of post-contrast kidney injury in patients with cancer. Drugs in context 13 (2024)
Francesco Angelico
Chronic liver disease and management with silymarin: an introductory review of a clinical case collection. Drugs in context 13 (2024)
Francesco Angelico, Diana Alcantara-Payawal, Rafiz Abdul Rani, Norlaila Mustafa, Nuntakorn Thongtang, Roongruedee Chaiteerakij, Chalermrat Bunchorntavakul, Apichard Sukonthasarn
Review and expert opinion on MAFLD, oxidative stress and multifunctional management. Drugs in context 13 (2024)
Petra Staubach, Andreas Körber, Ralph M Trüeb, Caroline Mann, Ralph von Kiedrowski
A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar ® ) in the management of psoriasis with scalp involvement. Drugs in context 13 (2024)
Tirsit Kestela Zeleke, Bekalu Dessie Alamirew, Zegaye Agmassie Bazezew, Muluken Adela Alemu, Abdisa Gemedi Jara, Rahel Belete Abebe
The magnitude and predictors of self-medication amongst street dwellers in Ethiopia: a multicentre study. Drugs in context 13 (2024)
Jenna Januszka, Emily Drwiega, Rodrigo Burgos, Renata Smith, Melissa Badowski
Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy. Drugs in context 13 (2024)
David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers. Drugs in context 13 (2024)
Rahel Belete Abebe, Bezawit Mulat Ayal, Muluken Adela Alemu, Tirsit Kestela Zeleke
Antibiotic appropriateness at outpatient settings in Ethiopia: the need for an antibiotic stewardship programme. Drugs in context 13 (2024)
Michael Langworthy, Peter Lascarides, Wilson Ngai, Kevin Steele, Yili Huang
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial. Drugs in context 13 (2024)
José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar
Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts. Drugs in context 13 (2024)
Emanuele Grassedonio, Lorena Incorvaia, Marco Guarneri, Fabio Guagnini, Massimo Midiri
Prevention of post-contrast kidney injury in patients with cancer. Drugs in context 13 (2024)
David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet
Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers. Drugs in context 13 (2024)
Raffaella Palumbo, Erica Quaquarini, Giuseppe Saltalamacchia, Alberto Malovini, Pietro Lapidari, Barbara Tagliaferri, Ludovica Mollica, Cristina Maria Teragni, Chiara Barletta, Laura Deborah Locati, Federico Sottotetti
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR + /HER2 - metastatic breast cancer: a prospective, monocentric study. Drugs in context 13 (2024)
Laura Cristina López Vargas, David Chávez Gallegos, Dolly Marlene Blanco Borjas, Veronika J Wirtz
Medicines policy, access and use in Mexico: a systematic literature review 2000-2022. Drugs in context 13 (2024)
Tirsit Kestela Zeleke, Bekalu Dessie Alamirew, Zegaye Agmassie Bazezew, Muluken Adela Alemu, Abdisa Gemedi Jara, Rahel Belete Abebe
The magnitude and predictors of self-medication amongst street dwellers in Ethiopia: a multicentre study. Drugs in context 13 (2024)
Niklas Garde, Markus Heibel
Effect of nabiximols oromucosal spray (Sativex ® ) on symptoms associated with multiple sclerosis-related spasticity: a case series. Drugs in context 13 (2024)
Iñaki Izquierdo, Laia Casas, Susana Cabrera, Alberto Fernandez
How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review. Drugs in context 13 (2024)
José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar
Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts. Drugs in context 13 (2024)
Jenna Januszka, Emily Drwiega, Rodrigo Burgos, Renata Smith, Melissa Badowski
Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy. Drugs in context 13 (2024)
Francesco Angelico, Diana Alcantara-Payawal, Rafiz Abdul Rani, Norlaila Mustafa, Nuntakorn Thongtang, Roongruedee Chaiteerakij, Chalermrat Bunchorntavakul, Apichard Sukonthasarn
Review and expert opinion on MAFLD, oxidative stress and multifunctional management. Drugs in context 13 (2024)
Andrea Jetzú Bautista Gómez, Maricela López Orozco, Liliana Barajas Esparza, Hermelinda de La Cruz Durán, Alejandro Chehue Romero, Isis Beatriz Bermúdez Camps, Ana María Téllez López, Laura Cristina López Vargas, Maria-Isabel Valverde-Merino, Fernando Martínez Martínez, Ivette Reyes Hernández
Feasibility and reliability of a quality indicator system for an ambulatory dispensing service. Drugs in context 13 (2024)
Petra Staubach, Andreas Körber, Ralph M Trüeb, Caroline Mann, Ralph von Kiedrowski
A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar ® ) in the management of psoriasis with scalp involvement. Drugs in context 13 (2024)
Sara Munari, Giulia Ciotti, Walter Cestaro, Lorenzo Corsi, Silvia Tonin, Andrea Ballarin, Ariel Floriani, Cristina Dartora, Annamaria Bosi, Matteo Tacconi, Francesco Gialdini, Michele Gottardi, Francesco Menzella
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review. Drugs in context 13 (2024)
Rahel Belete Abebe, Bezawit Mulat Ayal, Muluken Adela Alemu, Tirsit Kestela Zeleke
Antibiotic appropriateness at outpatient settings in Ethiopia: the need for an antibiotic stewardship programme. Drugs in context 13 (2024)
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mosges, Zoltan Novak, Papadopoulos G Nikolaos, Pablo Rodríguez Del Río, null null
Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study. Drugs in context 13 (2024)
Irsan Hasan, Ignatia Sinta Murti, Putut Bayupurnama, Kemal Fariz Kalista, Christina Hill-Zabala, Dennis Kananda, Elisabet Viayna
Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings. Drugs in context 13 (2024)
Sabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, Denise Costa, Christine De Acetis, Patrizia Gargiulo, Antonella Giampietro, Andrea M Isidori, Marie-Lise Jaffrain-Rea, Marina Passeri, Francesca Pigliaru, Maurizio Poggi, Laura De Marinis
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences. Drugs in context 13 (2024)
Michael Langworthy, Peter Lascarides, Wilson Ngai, Kevin Steele, Yili Huang
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial. Drugs in context 13 (2024)
Michael Langworthy, Peter Lascarides, Wilson Ngai, Kevin Steele, Yili Huang
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial. Drugs in context 13 (2024)
Bernardo Rossini, Nicola Cecchi, Felice Clemente, Maria Rosaria De Paolis, Stefan Hohaus, Vanessa Innao, Mariano Lucignano, Roberto Massaiu, Giovanna Palumbo, Gian Matteo Rigolin, Francesca Gaia Rossi, Luisa Verga, Attilio Guarini
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. Drugs in context 13 (2024)
Dhyuti Gupta, Prithpal Singh Matreja, Shilpa Patrick, Meenu Thomas, Pooja Agarwal, Preeti Singh
Assessment of knowledge, attitude and practice of fixed-dose combinations amongst attending physicians and residents: a cross-sectional evaluation. Drugs in context 13 (2024)
Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study. Drugs in context 13 (2024)
Bernardo Rossini, Nicola Cecchi, Felice Clemente, Maria Rosaria De Paolis, Stefan Hohaus, Vanessa Innao, Mariano Lucignano, Roberto Massaiu, Giovanna Palumbo, Gian Matteo Rigolin, Francesca Gaia Rossi, Luisa Verga, Attilio Guarini
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. Drugs in context 13 (2024)
Coral González Fernández, Jose Antonio Ros Lucas, Maria Molina Molina, Juan Rigual Bobillo, Rogelio Alejandro García Montenegro, Raquel Fernández González, Ana Jaureguiza Oriol, Jose Abal Arca
Autoimmune findings in patients with silicosis in Spain. Drugs in context 13 (2024)
Nicoletta Bernardini, Annunziata Dattola, Giacomo Caldarola, Diego Orsini, Chiara Assorgi, Alessandra D'Amore, Giulia Maretti, Antonio Giovanni Richetta, Ersilia Tolino, Nevena Skroza, Concetta Potenza
Rapid response on facial psoriasis to bimekizumab: case series. Drugs in context 13 (2024)
Francesco Angelico
Chronic liver disease and management with silymarin: an introductory review of a clinical case collection. Drugs in context 13 (2024)
Raffaella Palumbo, Erica Quaquarini, Giuseppe Saltalamacchia, Alberto Malovini, Pietro Lapidari, Barbara Tagliaferri, Ludovica Mollica, Cristina Maria Teragni, Chiara Barletta, Laura Deborah Locati, Federico Sottotetti
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR + /HER2 - metastatic breast cancer: a prospective, monocentric study. Drugs in context 13 (2024)
Andrea Jetzú Bautista Gómez, Maricela López Orozco, Liliana Barajas Esparza, Hermelinda de La Cruz Durán, Alejandro Chehue Romero, Isis Beatriz Bermúdez Camps, Ana María Téllez López, Laura Cristina López Vargas, Maria-Isabel Valverde-Merino, Fernando Martínez Martínez, Ivette Reyes Hernández
Feasibility and reliability of a quality indicator system for an ambulatory dispensing service. Drugs in context 13 (2024)
Sabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, Denise Costa, Christine De Acetis, Patrizia Gargiulo, Antonella Giampietro, Andrea M Isidori, Marie-Lise Jaffrain-Rea, Marina Passeri, Francesca Pigliaru, Maurizio Poggi, Laura De Marinis
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences. Drugs in context 13 (2024)
Niklas Garde, Markus Heibel
Effect of nabiximols oromucosal spray (Sativex ® ) on symptoms associated with multiple sclerosis-related spasticity: a case series. Drugs in context 13 (2024)
Iñaki Izquierdo, Laia Casas, Susana Cabrera, Alberto Fernandez
How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review. Drugs in context 13 (2024)
José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar
Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts. Drugs in context 13 (2024)
Kayla R Stover, Taylor E Jordan, Jamie L Wagner, Katie E Barber
High-dose amphotericin: yay or nay? A case series and literature review. Drugs in context 13 (2024)